Therapeutic area Diagnostics
What the technology does
Polymerases capable of processing unnatural, xeno-nucleic acid (XNA) : alternative genetic polymers not found in nature
Polymerases with the ability to process unnatural nucleic acids have been selected and evolved using a proprietary in vitro evolution technology, providing the tools to process a range of XNAs including ANA, FANA, CeNA, PNA and HNA.
Main application field
Various enzymes are available for processing of XNA, providing the tools for performance of selection and evolution of XNA aptamers with properties advantageous for diagnostic and therapeutic development
Technology ready for evaluation and licensing
Patents filed 14-04-2011 (PCT/GB2011/000583), and 19-04-2012 (PCT/GB2013/050991).